J Matthias Löhr1, Enrique Dominguez-Munoz2, Jonas Rosendahl3, Marc Besselink4, Julia Mayerle5, Markus M Lerch6, Stephan Haas1, Fatih Akisik7, Nikolaos Kartalis8, Julio Iglesias-Garcia2, Jutta Keller9, Marja Boermeester4, Jens Werner10, Jean-Marc Dumonceau11, Paul Fockens12, Asbjorn Drewes13, Gürlap Ceyhan14, Björn Lindkvist15, Joost Drenth16, Nils Ewald17, Philip Hardt17, Enrique de Madaria18, Heiko Witt19, Alexander Schneider20, Riccardo Manfredi21, Frøkjer J Brøndum22, Sasa Rudolf23, Thomas Bollen24, Marco Bruno25. 1. Center for Digestive Diseases, Karolinska University Hospital, Stockholm, Sweden. 2. Department of Gastroenterology and Hepatology, University Hospital of Santiago de Compostela, Santiago de Compostela, Spain. 3. Department of Gastroenterology, University of Leipzig, Leipzig, Germany. 4. Department of Surgery, Academic Medical Center Amsterdam, the Netherlands. 5. Medizinische Klinik und Poliklinik 2, Klinikum der Ludwig-Maximilians-Universität, Munich, Germany. 6. Department of Medicine A, University Medicine Greifswald, Greifswald, Germany. 7. Department of Radiology, Indiana University, Indianapolis, USA. 8. Department of Radiology, Karolinska University Hospital and Division of Medical Imaging and Technology, CLINTEC, Karolinska Institutet, Stockholm, Sweden. 9. Israelitic Hospital Hamburg, University of Hamburg, Hamburg, Germany. 10. Ludwig Maximilians University, Munich, Germany. 11. University of Geneve, Geneva, Switzerland. 12. Department of Surgery, Academic Medical Center Amsterdam, the Netherlands; Department of Gastroenterology and Hepatology, Academic Medical Center, Amsterdam, The Netherlands. 13. Department of Gastroenterology, Aarhus University, Aarhus, Denmark. 14. Klinikum Rechts der Isar, Technical University Munich, Germany. 15. Göteborgs Universitet, Gothenburg, Sweden. 16. Department of Gastroenterology and Hepatology, Radboud University Medical Center, Nijmegen, The Netherlands. 17. Justus-Liebig-Universität Giessen, Giessen, Germany. 18. Hospital General Universitario, Alicante, Spain. 19. Technical University Munich, Munich, Germany. 20. University Hospital Mannheim, Mannheim, Germany. 21. Department of Radiology, University of Verona, Verona, Italy. 22. Aalborg University, Aalborg, Denmark. 23. Department of Radiology, University Medical Centre Maribor, Maribor, Slovenia. 24. St Antonius Ziekenhuis, Nieuwegein, The Netherland. 25. Department of Gastroenterology and Hepatology, Erasmus Medical Centre in Rotterdam, The Netherlands.
Abstract
BACKGROUND: There have been substantial improvements in the management of chronic pancreatitis, leading to the publication of several national guidelines during recent years. In collaboration with United European Gastroenterology, the working group on 'Harmonizing diagnosis and treatment of chronic pancreatitis across Europe' (HaPanEU) developed these European guidelines using an evidence-based approach. METHODS: Twelve multidisciplinary review groups performed systematic literature reviews to answer 101 predefined clinical questions. Recommendations were graded using the Grading of Recommendations Assessment, Development and Evaluation system and the answers were assessed by the entire group in a Delphi process online. The review groups presented their recommendations during the 2015 annual meeting of United European Gastroenterology. At this one-day, interactive conference, relevant remarks were voiced and overall agreement on each recommendation was quantified using plenary voting (Test and Evaluation Directorate). After a final round of adjustments based on these comments, a draft version was sent out to external reviewers. RESULTS: The 101 recommendations covered 12 topics related to the clinical management of chronic pancreatitis: aetiology (working party (WP)1), diagnosis of chronic pancreatitis with imaging (WP2 and WP3), diagnosis of pancreatic exocrine insufficiency (WP4), surgery in chronic pancreatitis (WP5), medical therapy (WP6), endoscopic therapy (WP7), treatment of pancreatic pseudocysts (WP8), pancreatic pain (WP9), nutrition and malnutrition (WP10), diabetes mellitus (WP11) and the natural course of the disease and quality of life (WP12). Using the Grading of Recommendations Assessment, Development and Evaluation system, 70 of the 101 (70%) recommendations were rated as 'strong' and plenary voting revealed 'strong agreement' for 99 (98%) recommendations. CONCLUSIONS: The 2016 HaPanEU/United European Gastroenterology guidelines provide evidence-based recommendations concerning key aspects of the medical and surgical management of chronic pancreatitis based on current available evidence. These recommendations should serve as a reference standard for existing management of the disease and as a guide for future clinical research.
BACKGROUND: There have been substantial improvements in the management of chronic pancreatitis, leading to the publication of several national guidelines during recent years. In collaboration with United European Gastroenterology, the working group on 'Harmonizing diagnosis and treatment of chronic pancreatitis across Europe' (HaPanEU) developed these European guidelines using an evidence-based approach. METHODS: Twelve multidisciplinary review groups performed systematic literature reviews to answer 101 predefined clinical questions. Recommendations were graded using the Grading of Recommendations Assessment, Development and Evaluation system and the answers were assessed by the entire group in a Delphi process online. The review groups presented their recommendations during the 2015 annual meeting of United European Gastroenterology. At this one-day, interactive conference, relevant remarks were voiced and overall agreement on each recommendation was quantified using plenary voting (Test and Evaluation Directorate). After a final round of adjustments based on these comments, a draft version was sent out to external reviewers. RESULTS: The 101 recommendations covered 12 topics related to the clinical management of chronic pancreatitis: aetiology (working party (WP)1), diagnosis of chronic pancreatitis with imaging (WP2 and WP3), diagnosis of pancreatic exocrine insufficiency (WP4), surgery in chronic pancreatitis (WP5), medical therapy (WP6), endoscopic therapy (WP7), treatment of pancreatic pseudocysts (WP8), pancreatic pain (WP9), nutrition and malnutrition (WP10), diabetes mellitus (WP11) and the natural course of the disease and quality of life (WP12). Using the Grading of Recommendations Assessment, Development and Evaluation system, 70 of the 101 (70%) recommendations were rated as 'strong' and plenary voting revealed 'strong agreement' for 99 (98%) recommendations. CONCLUSIONS: The 2016 HaPanEU/United European Gastroenterology guidelines provide evidence-based recommendations concerning key aspects of the medical and surgical management of chronic pancreatitis based on current available evidence. These recommendations should serve as a reference standard for existing management of the disease and as a guide for future clinical research.
Entities:
Keywords:
Chronic pancreatitis; Development and Evaluation; Grading of Recommendations Assessment; diabetes mellitus; endoscopic therapy; evidence-based; guidelines; pancreatic exocrine insufficiency
Authors: Søren Schou Olesen; Henrik Krarup; Jakob Lykke Poulsen; Jeppe Hagstrup Christensen; Andrea Rhiannon Glynne Sheel; Robert Sutton; William Greenhalf; Christopher Halloran; Asbjørn Mohr Drewes Journal: United European Gastroenterol J Date: 2019-04-16 Impact factor: 4.623
Authors: Sarah J Schwarzenberg; Aliye Uc; Bridget Zimmerman; Michael Wilschanski; C Mel Wilcox; David C Whitcomb; Steven L Werlin; David Troendle; Gong Tang; Adam Slivka; Vikesh K Singh; Stuart Sherman; Uzma Shah; Bimaljit S Sandhu; Joseph Romagnuolo; Sue Rhee; John F Pohl; Emily R Perito; Chee Y Ooi; Jaimie D Nathan; Thiruvengadam Muniraj; Veronique D Morinville; Brian McFerron; Maria Mascarenhas; Asim Maqbool; Quin Liu; Tom K Lin; Michele Lewis; Sohail Z Husain; Ryan Himes; Melvin B Heyman; Nalini Guda; Tanja Gonska; Matthew J Giefer; Andres Gelrud; Cheryl E Gariepy; Timothy B Gardner; Steven D Freedman; Christopher E Forsmark; Douglas S Fishman; Gregory A Cote; Darwin Conwell; Randall E Brand; Melena Bellin; Bradley Barth; Peter A Banks; Michelle A Anderson; Stephen T Amann; Samer Alkaade; Maisam Abu-El-Haija; Judah N Abberbock; Mark E Lowe; Dhiraj Yadav Journal: J Pediatr Gastroenterol Nutr Date: 2019-04 Impact factor: 2.839
Authors: Chris E Forsmark; Gong Tang; Hongzhi Xu; Marie Tuft; Steven J Hughes; Dhiraj Yadav Journal: Aliment Pharmacol Ther Date: 2020-04-06 Impact factor: 8.171
Authors: Benjamin M Shandro; Jennifer Ritehnia; Joshua Chen; Rani Nagarajah; Andrew Poullis Journal: Clin Med (Lond) Date: 2020-11 Impact factor: 2.659